Simvastatin to Prevent SCI-Induced Bone Loss

Status unconfirmed · Phase 2 · Has a placebo group

Conditions studied: Spinal Cord Injuries, Osteoporosis

In brief

This is a double blind, randomized, placebo -controlled clinical trial with the primary goal of determining the osteogenic benefits of simvastatin in acute SCI.

Key facts

Study ID
NCT02946424
Run by
Craig Hospital
People needed
76
Starts
2017-07-01
Expected to finish
2023-09-30
Last updated by the study team
2021-12-08

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.